Tislelizumab (anti-PD-1 monoclonal antibody) should be individualized for patients in special populations, with key considerations for pregnant women,···【Read More】
Update: 2026-02-27Source: Haiou HealthViews: 159
Patients treated with tislelizumab injection should focus on adverse reaction monitoring, infection prevention and management of special populations, ···【Read More】
Update: 2026-02-27Source: Haiou HealthViews: 145
As an immunotherapeutic agent (PD-1 inhibitor), the main side effects of tislelizumab stem from an overactivated immune system attacking normal body t···【Read More】
Update: 2026-02-27Source: Haiou HealthViews: 158
The recommended standard dosage of Tislelizumab for adults is 200 mg administered via intravenous infusion, once every 3 weeks.The specific dosage sha···【Read More】
Update: 2026-02-27Source: Haiou HealthViews: 151
Tislelizumab is an antineoplastic biological agent, with the active ingredient being a humanized recombinant anti-PD-1 monoclonal antibody. It mainly ···【Read More】
Update: 2026-02-27Source: Haiou HealthViews: 159
Fruquintinib is a targeted therapy used for metastatic colorectal cancer, and its administration requires strict attention to contraindications. Altho···【Read More】
Update: 2026-02-26Source: Haiou HealthViews: 164
The use of fruquintinib must be strictly guided by a doctor, with key focus on monitoring adverse reactions, drug interactions and lifestyle adjustmen···【Read More】
Update: 2026-02-26Source: Haiou HealthViews: 177
Fruquintinib Capsules is an antineoplastic drug mainly used for the treatment of metastatic colorectal cancer. Its common side effects include hyperte···【Read More】
Update: 2026-02-26Source: Haiou HealthViews: 144
The administration of fruquintinib must follow strict medical guidance. It is commonly indicated for the treatment of metastatic colorectal cancer. Th···【Read More】
Update: 2026-02-26Source: Haiou HealthViews: 146
Fruquintinib capsules are a dedicated tumor angiogenesis inhibitor. They exert their effects mainly by blocking the VEGFR kinase family (three key tar···【Read More】
Update: 2026-02-26Source: Haiou HealthViews: 154
Rezvilutamide Tablets are a novel androgen receptor inhibitor, mainly indicated for the treatment of prostate cancer. Administration in special popula···【Read More】
Update: 2026-02-25Source: Haiou HealthViews: 149
Rezvilutamide Tablets is a prescription medication for the treatment of certain types of prostate cancer and must be used strictly under medical super···【Read More】
Update: 2026-02-25Source: Haiou HealthViews: 146
Rezvilutamide Tablets are an anti-androgen medication used for the treatment of prostate cancer. Their side effects mainly involve the endocrine, dige···【Read More】
Update: 2026-02-25Source: Haiou HealthViews: 140
The dosage of Rezvilutamide Tablets must be administered in strict accordance with medical advice. The usual recommended dose is 300 mg (3 tablets) on···【Read More】
Update: 2026-02-25Source: Haiou HealthViews: 162
Rezvilutamide Tablets belong to the second-generation androgen receptor (AR) inhibitors and represent China's first independently developed novel ···【Read More】
Update: 2026-02-25Source: Haiou HealthViews: 123
Copyright 2024 @ haiouhealth.com All right reserved Seagull health | Bigbear Pharmaceutical | Lucius Pharmaceuticals | 老挝全球药房